Posts

BeOne boosts US footprint with $300M New Jersey expansion

on

Bipartisan Senate bill seeks to build vigilance around foreign companies making drugs in US

on

Radiopharma maker AdvanCell hauls in $315M for Pluvicto challenger | ADVC001 lead-212 PSMA-targeted therapy and manufacturing expansion

on

FDA Proposes Streamlined Requirements for Hub‑and‑Spoke Drug Manufacturing Models

on

Cellares and Sonoma Biotherapeutics Collaborate to Automate Manufacturing of SBT-77-7101 Engineered Treg Cell Therapy on the Cell Shuttle Platform

on

BIO 2026: Cell and gene therapy sector must break the mold to thrive

on

Medline Faces FDA Warning Over Repeat *Bacillus cereus* Contamination in Drug Products

on

Gilead's Hepcludex Wins FDA Approval for Hepatitis D After Prior Manufacturing Snag

on

Bora snaps up MacroGenics' manufacturing, CDMO operations for up to $127.5M

on

Amgen Announces Additional $300M Investment in Puerto Rico Manufacturing Facility

on

Novartis to Cut 220 Jobs as Wehr, Germany Site Closes by 2028

on

10 Critical Success Factors for Commercializing Cell & Gene Therapies

on

Novartis Breaks Ground on Flagship North Carolina Manufacturing Hub as Key Milestone in $23B US Expansion

on

Shionogi Receives $119M BARDA Award to Establish US Antibiotic Manufacturing Plant

on

Pharma Industry's Reshoring Boom: Massive Investments Amid Tariff Pressures

on

Novartis Commits $480M to Expand Manufacturing and R&D in China Following AstraZeneca and Lilly

on

AstraZeneca Announces Cell Therapy Manufacturing Hub and R&D Center in Shanghai

on

Orca Bio Presents Clinical Data on High-Precision Cell Therapies at 52nd EBMT Annual Meeting

on

AbbVie Invests $380 Million in Active Pharmaceutical Ingredient Manufacturing Expansion in North Chicago, Illinois

on

Eli Lilly Commits $3.5 Billion to Build Injectable Obesity Drug Plant in Pennsylvania

on